The economic evaluation of pharmacotherapies for Parkinson's disease

被引：12
作者：
Coyle, D
Barbeau, A
Guttman, M
Baladi, JF
机构：
[1] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Clin Epidemiol Unit,Dept Med & Epidemiol, Ottawa, ON K1Y 4E9, Canada
[2] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Clin Epidemiol Unit,Dept Community Med, Ottawa, ON K1Y 4E9, Canada
[3] Novartis Pharma Canada Inc, Dorval, PQ, Canada
[4] Ctr Movement Disorders, Markham, ON, Canada
[5] Univ Toronto, Div Neurol, Dept Med & Psychiat, Toronto, ON, Canada
来源：
PARKINSONISM & RELATED DISORDERS | 2003年 / 9卷 / 05期
关键词：
health economics; cost-effectiveness; economic evaluation; Parkinson's disease;
D O I：
10.1016/S1353-8020(02)00116-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
As well as the significant clinical effects of Parkinson's disease (PD), the disease places a high economic burden on society. Given the scarcity of health care resources, it is becoming increasingly necessary to demonstrate that new therapies for PD provide value for money in comparison with other potential interventions. This paper outlines the basic techniques of cost-effectiveness analysis and its application to PD. These techniques are illustrated by a recent economic evaluation of entacapone for use in Canada. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：301 / 307
页数：7
相关论文
共 50 条
  • [11] An exercise intervention to prevent falls in Parkinson's: an economic evaluation
    Fletcher, Emily
    Goodwin, Victoria A.
    Richards, Suzanne H.
    Campbell, John L.
    Taylor, Rod S.
    [J]. BMC HEALTH SERVICES RESEARCH, 2012, 12 : 426
  • [12] An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
    Emily Fletcher
    Victoria A Goodwin
    Suzanne H Richards
    John L Campbell
    Rod S Taylor
    [J]. BMC Health Services Research, 12
  • [13] Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson's Disease in The Netherlands
    van Boven, Job F. M.
    Novak, Annoesjka
    Driessen, Maurice T.
    Boersma, Cornelis
    Boomsma, Maarten M.
    Postma, Maarten J.
    [J]. DRUGS & AGING, 2014, 31 (03) : 193 - 201
  • [14] Clinical and economic analysis of spa therapy in Parkinson's disease
    Brefel-Courbon, C
    Desboeuf, K
    Thalamas, C
    Galitzky, M
    Senard, JM
    Rascol, O
    Montastruc, JL
    [J]. MOVEMENT DISORDERS, 2003, 18 (05) : 578 - 584
  • [15] Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease
    Puig-Junoy, J.
    Puig Peiro, R.
    [J]. NEUROLOGIA, 2009, 24 (04): : 220 - 229
  • [16] Preoperative Evaluation of Parkinson's Disease
    Woodruff, Bianca C.
    Garcia, David
    Chaudhari, Shobhana
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [17] Evaluation of Models of Parkinson's Disease
    Jagmag, Shail A.
    Tripathi, Naveen
    Shukla, Sunil D.
    Maiti, Sankar
    Khurana, Sukant
    [J]. FRONTIERS IN NEUROSCIENCE, 2016, 9
  • [18] Evaluation of Parkinson's disease in entrants on the Nebraska state Parkinson's disease Registry
    Bertoni, John M.
    Sprenkle, Pamela M.
    Strickland, Daniel
    Noedel, Nancy
    [J]. MOVEMENT DISORDERS, 2006, 21 (10) : 1623 - 1626
  • [19] Evaluation of the Parkinson's KinetiGraph in monitoring and managing Parkinson's disease
    Farzanehfar, Parisa
    Horne, Malcolm
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2017, 14 (08) : 583 - 591
  • [20] Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation
    Norlin, Jenny M.
    Willis, Michael
    Persson, Ulf
    Andersson, Emelie
    Palhagen, Sven E.
    Odin, Per
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2021, 144 (02): : 170 - 178
12345